Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Pivotal, First - in Man Clinical Trial of the Safety and Efficacy of a Novel Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease

NCT02145065 is registered in ClinicalTrials.gov with Balton Sp.zo.o. as lead sponsor.

NCT NCT02145065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Pivotal, First - in Man Clinical Trial of the Safety and Efficacy of a Novel Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease
Lead sponsor
Balton Sp.zo.o.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2017
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoropopliteal artery disease, peripheral artery disease